Capital International Inc. CA Sells 380,763 Shares of Bristol Myers Squibb Company

The institutional investor reduced its stake in the biopharmaceutical company by over 50% in Q3 2025.

Mar. 11, 2026 at 8:25am

Got story updates? Submit your updates here. ›

Capital International Inc. CA, an institutional investor, reduced its holdings in Bristol Myers Squibb Company (NYSE:BMY) by 52.3% in the 3rd quarter of 2025, according to a filing with the Securities and Exchange Commission. The investor now owns 346,863 shares of the biopharmaceutical company's stock, worth $15.6 million as of the most recent filing.

Why it matters

This transaction reflects broader trends in the institutional investment landscape, as fund managers adjust their portfolios in response to market conditions and company performance. Bristol Myers Squibb is a major player in the biopharmaceutical industry, so changes in institutional ownership of its stock can provide insights into investor sentiment around the company.

The details

Capital International Inc. CA sold 380,763 shares of Bristol Myers Squibb, reducing its total stake in the company by over 50%. The investor now holds 346,863 shares, worth $15.6 million as of the most recent SEC filing. This transaction comes as Bristol Myers Squibb navigates a competitive landscape in the biopharmaceutical industry, with the company focusing on advancing therapies in areas like oncology, hematology, and immunology.

  • Capital International Inc. CA filed the transaction details in the 3rd quarter of 2025.

The players

Capital International Inc. CA

An institutional investor that manages a portfolio of investments, including shares in Bristol Myers Squibb Company.

Bristol Myers Squibb Company

A global biopharmaceutical company headquartered in Princeton, New Jersey, focused on discovering, developing, and delivering medicines for serious diseases.

Got photos? Submit your photos here. ›

The takeaway

This transaction highlights the dynamic nature of institutional investment strategies, as fund managers continuously evaluate their holdings and make adjustments to align with their investment objectives. The reduction in Capital International Inc. CA's stake in Bristol Myers Squibb may signal a shift in investor sentiment around the company, though broader market and industry trends would need to be considered to fully understand the implications.